Librela

European Experience

100

This amount of doses have been dispensed in Europe since 2021.

6.8 Million

200

What percent of European Veterinarians used Librela as the main OA treatment for canine patients, with no other treatment required?

75%

300

In the EU field study, how many days did it take for the placebo group to notice no improvement?

56

MOA

100

This body part is most associated with OA pain

Joint

200

Librela specifically targets this within the body

Nerve Growth Factor (NGF)

300

Librela is what type of drug?

Monoclonal Antibody (mAb)

Safety

100

Librela was well tolerated at this many times the label dose.

10X

200

Any remaining liquid from a punctured vial must be discarded right away and not used twice, why?

There is no preservative in Librela.

300

What is the age limit for dogs to receive Librela?

Not specified: Recommended 12 month of age and older.